the underlying illness and the therapies provided influence red cell mass andplasma volume. In addition, despite the publication ofrandomized controlled trialsof transfusion strategies and guidelines for transfusion8, variation in practice inevitably will still exist. Such variation will influence ...
Concomitant anemia was identified based on ICD-9 codes or receipt of transfusions. Persons with anemia secondary to another disease state, a nutritional deficiency or a hereditary disease were excluded. Medicare claims and payments, resource utilization and mortality were compared between COPD patients ...
wAIHA ischaracterizedby evidence of red blood cell (RBC) hemolysis and a direct antiglobulin test positive for IgG and sometimes complement. While varying with the extent of the compensatory increase in RBC production, symptoms of anemia predominate, as does jaundice, t...
Transfusion therapy usually does not aim at keeping the Hb level higher than about 10 g/dl, and recent studies show important gains in QoL when Hb is increased from this level to above12 g/dl. A new concept: Improved response with IV iron addition There are two reasons why addition of ...
9 In hospitalized women with obstetric bleeding, anemia and blood transfusion are frequently documented, and the diagnosis of anemia was associated with increased total cost per hospitalization, and longer length of stay.10 Despite the clinical significance and increased health risks associated with ...
definitions and further assessed: (1) whether the patient was diagnosed with ICD9 or ICD10 codes for anemia and/or noted by the gastroenterologist in the clinic visit dictation to have anemia and (2) intiation of therapy regardless of method (oral, intravenous or red blood cell transfu...
Patients were classified into 3 cohorts: those who did not have a diagnosis of anemia and did not receive an RBC transfusion (the control group), those with acute blood loss anemia who did not receive a transfusion (the anemia without transfusion group), and those with acute blood loss ...
Symptomatic IDA was treated with blood transfusion in 46 (43%). Ferrous sulfate was the most commonly prescribed oral iron therapy. Seven patients received intravenous iron therapy either initially or after oral iron treatment failure. Combined oral contraceptives were commonly prescribed for abnormal ...
Dextriferron was the preferred iron formulation among hematologists, with a median dose of 5 mg/kg, with acceptable compliance rates (63.5–93.2%). Hospital admission rates varied among the centers (9.4–35%), and so did transfusion policies (6.4–22.9%). The greatest difference was observed...
CDA II patients exhibit a variable degree of anemia ranging from very severe, requiring red cell transfusions in utero [3,4], to moderate or mild; affected individuals with normal hemoglobin levels have also been reported [5]. Other clinical manifestations include jaundice, splenomegaly, and iron...